ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 4.500
0.00 (0.00%)
At close: Sep 26, 2025
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €72.51 million as of September 26, 2025. Its market cap has increased by 61.87% in one year.
Market Cap
72.51M
Enterprise Value
74.54M
Revenue
5.87M
Ranking
n/a
PE Ratio
225.00
Stock Price
€4.50
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 72.51M, an increase of 2,791.14%. That is a compound annual growth rate of 14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 72.51M | 82.93% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.29B |
| Sanofi | 95.30B |
| Sartorius Stedim Biotech | 16.69B |
| bioMérieux | 13.34B |
| Eurofins Scientific SE | 10.82B |
| Ipsen | 9.19B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |